DAVID NICKELS: Open Payments
NPI 1083345607 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,632 in 83 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $851 · 2025 $1,632
Food & beverage: $1,632
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 6 | $211 |
| ABBVIE INC. | 11 | $173 |
| PFIZER INC. | 13 | $163 |
| AstraZeneca Pharmaceuticals LP | 9 | $161 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $158 |
| Corcept Therapeutics | 5 | $113 |
| GlaxoSmithKline, LLC. | 5 | $82 |
| KYOWA KIRIN, INC. | 3 | $81 |
| SHIELD THERAPEUTICS INC | 3 | $65 |
| Lilly USA, LLC | 3 | $57 |
Products named: REZDIFFRA, CAPLYTA, NURTEC ODT, Korlym, AIRSUPRA, QULIPTA, TRELEGY ELLIPTA, CRYSVITA.
Industry payments across NY — which companies pay providers there.
